Silvercrest Asset Management Group LLC Pfizer Inc Transaction History

Silvercrest Asset Management Group LLC

$14.1 Billion
Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 768,570 shares of PFE stock, worth $21.5 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

768,570

Previous 777,085 1.1%

Holding current value

$21.5 Million

Previous $22.4 Million 4.67%

% of portfolio

0.15%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $220,453 - $253,150	-8,515 Reduced 1.1%	768,570 $21.3 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $3.43 Million - $4.46 Million	-131,390 Reduced 14.46%	777,085 $22.4 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $25.6 Million - $29.9 Million	-797,788 Reduced 46.76%	908,475 $30.1 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $12.7 Million - $14.7 Million	-352,856 Reduced 17.14%	1,706,263 $62.6 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $2.65 Million - $3.45 Million	-67,286 Reduced 3.16%	2,059,119 $84 Million

Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $1.13 Million - $1.47 Million	27,012 Added 1.29%	2,126,405 $109 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.52 Million - $1.85 Million	-34,719 Reduced 1.63%	2,099,393 $91.9 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.52 Million - $2.99 Million	54,185 Added 2.61%	2,134,112 $112 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.08 Million - $1.34 Million	23,694 Added 1.15%	2,079,927 $108 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $90,325 - $133,892	-2,186 Reduced 0.11%	2,056,233 $121 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $1.58 Million - $2.02 Million	-40,155 Reduced 1.91%	2,058,419 $88.5 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $824,709 - $934,256	-22,966 Reduced 1.08%	2,098,574 $82.2 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $1.2 Million - $1.35 Million	35,779 Added 1.72%	2,121,540 $76.9 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $468,144 - $595,286	13,987 Added 0.68%	2,085,761 $76.8 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $224,631 - $263,543	-7,075 Reduced 0.34%	2,071,774 $76 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $641,977 - $778,813	21,314 Added 1.04%	2,078,849 $68 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $12.3 Million - $17.5 Million	454,354 Added 28.34%	2,057,535 $67.2 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $474,607 - $538,619	14,417 Added 0.91%	1,603,181 $62.8 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $668,871 - $867,330	-20,587 Reduced 1.28%	1,588,764 $57.1 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $423,864 - $475,902	-11,462 Reduced 0.71%	1,609,351 $69.7 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $34.9 Million - $38.3 Million	-929,840 Reduced 36.45%	1,620,813 $68.8 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $23.8 Million - $27.1 Million	-617,711 Reduced 19.5%	2,550,653 $111 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $69,353 - $84,121	2,012 Added 0.06%	3,168,364 $140 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $4.97 Million - $5.3 Million	-150,764 Reduced 4.55%	3,166,352 $115 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $1.37 Million - $1.59 Million	43,021 Added 1.31%	3,317,116 $118 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $9.05 Million - $9.6 Million	271,964 Added 9.06%	3,274,095 $119 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $93.1 Million - $103 Million	3,002,131	3,002,131 $107 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Pfizer Inc Transaction History